Amgen Inc.
METHODS OF TREATING HEART FAILURE BY ADMINISTERING OMECAMTIV MECARBIL
Last updated:
Abstract:
Provided herein are methods of treating heart failure in patients exhibiting one or more additional features, comprising administering to the patient a therapeutically effective amount of omecamtiv mecarbil, or a hydrate, salt, or salt of a hydrate thereof.
Status:
Application
Type:
Utility
Filling date:
11 Nov 2021
Issue date:
16 Jun 2022